Sifrol®    (DrugBank: -)

1 disease
IDDisease name (Link within this page)Number of trials
6Parkinson disease6

6. Parkinson disease    [ 2,123 clinical trials,   2,046 drugs,   (DrugBank: 324 drugs),   183 drug target genes,   198 drug target pathways]
Searched query = "Parkinson disease"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
6 / 2,123 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT02248181
(ClinicalTrials.gov)
February 200422/9/2014Post Marketing Surveillance Study of Sifrol® in Patients With Idiopathic Parkinson's DiseasePost Marketing Surveillance Study of Sifrol® - Monotherapy in Patients With Idiopathic Parkinson's DiseaseParkinson DiseaseDrug: PramipexoleBoehringer IngelheimNULLCompletedN/AN/ABoth442N/ANULL
2NCT02231905
(ClinicalTrials.gov)
January 20043/9/2014Safety, Tolerability and Efficacy of Switching From Talipexole to Pramipexole in Patients With Parkinson's DiseaseOpen Label, Exploratory Clinical Trial to Assess the Safety, Tolerability and Effectiveness of a Switching From Talipexole to PramipexoleParkinson DiseaseDrug: BI-Sifrol®Boehringer IngelheimNULLCompleted20 YearsN/ABoth29Phase 4NULL
3NCT02248207
(ClinicalTrials.gov)
January 200322/9/2014Tolerability of Sifrol® in Ambulatory Patients Suffering From Parkinson's DiseaseManagement of Parkinson's Disease Patients at Their First Visits in a Neurological PracticeParkinson DiseaseDrug: PramipexoleBoehringer IngelheimNULLCompletedN/AN/ABoth1293N/ANULL
4NCT02231255
(ClinicalTrials.gov)
February 20022/9/2014Post Marketing Surveillance Study in Patients With Idiopathic Parkinson's DiseaseSwitch Post Marketing Surveillance Study in Patients With Idiopathic Parkinson's DiseaseParkinson DiseaseDrug: Sifrol®Boehringer IngelheimNULLCompletedN/AN/ABoth1216N/ANULL
5NCT02231294
(ClinicalTrials.gov)
July 20002/9/2014The Effect of Sifrol® on Tremor and Depression in Patients With Idiopathic Parkinson's DiseaseThe Effect of SIFROL® on Tremor and Depression in Patients With Idiopathic Parkinson's Disease Patients.Parkinson DiseaseDrug: Sifrol®Boehringer IngelheimNULLCompletedN/AN/ABoth1464N/ANULL
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
6NCT02248220
(ClinicalTrials.gov)
October 199822/9/2014Efficacy and Tolerability of Sifrol® (Pramipexole) in Patients With Advanced Idiopathic Parkinson's DiseaseObservation of the Efficacy and Tolerability of Sifrol® (Pramipexole) in Patients With Advanced Idiopathic Parkinson's DiseaseParkinson DiseaseDrug: PramipexoleBoehringer IngelheimNULLCompletedN/AN/ABoth657N/ANULL